Frontlight ResearchEarly access
Trial site
Hôpitaux Universitaires Genève HUG
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer3 trials
- Coronary artery disease2 trials
- Bladder cancer1 trial
- Hidradenitis suppurativa1 trial
- Lung cancer1 trial
- Phase
- Phase 23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Swiss Cancer Institute5 trials
- Boehringer Ingelheim1 trial
- CathWorks Ltd.1 trial
- Shockwave Medical, Inc.1 trial
Running trials
Recruiting
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Recruiting
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruiting
Active, not recruiting
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
Active, not recruiting
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
Active, not recruiting
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026